103 related articles for article (PubMed ID: 3690534)
1. Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Smith DB; Scarffe JH; Wagstaff J; Johnston RJ
Cancer Treat Rep; 1987 Dec; 71(12):1265-6. PubMed ID: 3690534
[TBL] [Abstract][Full Text] [Related]
2. Recombinant interferon alfa-2b in plaque-phase mycosis fungoides. Intralesional and low-dose intramuscular therapy.
Vonderheid EC; Thompson R; Smiles KA; Lattanand A
Arch Dermatol; 1987 Jun; 123(6):757-63. PubMed ID: 3579357
[TBL] [Abstract][Full Text] [Related]
3. Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.
Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Israel L; Falcoff E; Schwab D; Pouillart P
Cancer; 1986 Jul; 58(2):215-8. PubMed ID: 3719515
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of rDNA human alpha-2 interferon in multiple myeloma.
Wagstaff J; Loynds P; Scarffe JH
Cancer Treat Rep; 1985 May; 69(5):495-8. PubMed ID: 4005872
[TBL] [Abstract][Full Text] [Related]
5. Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity.
Oberg K; Alm G; Magnusson A; Lundqvist G; Theodorsson E; Wide L; Wilander E
J Natl Cancer Inst; 1989 Apr; 81(7):531-5. PubMed ID: 2466128
[TBL] [Abstract][Full Text] [Related]
6. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome.
Oberg K; Funa K; Alm G
N Engl J Med; 1983 Jul; 309(3):129-33. PubMed ID: 6191217
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phase.
Case DC; Sonneborn HL; Paul SD; Hiebel J; Boyd MA; Shepp MA; Dorsk BM; Bonnem E
Cancer Treat Rep; 1986 Nov; 70(11):1251-4. PubMed ID: 3768870
[TBL] [Abstract][Full Text] [Related]
8. A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour.
Veenhof CH; de Wit R; Taal BG; Dirix LY; Wagstaff J; Hensen A; Huldij AC; Bakker PJ
Eur J Cancer; 1992; 28(1):75-8. PubMed ID: 1373635
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of metastasized carcinoid tumor of the ileum and cecum with recombinant alpha-2b interferon].
Doberauer C; Niederle N; Kloke O; Kurschel E; Schmidt CG
Onkologie; 1987 Dec; 10(6):340-4. PubMed ID: 2450326
[TBL] [Abstract][Full Text] [Related]
10. Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon.
Moertel CG; Rubin J; Kvols LK
J Clin Oncol; 1989 Jul; 7(7):865-8. PubMed ID: 2738623
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon.
Funa K; Alm GV; Rönnblom L; Oberg K
Clin Exp Immunol; 1983 Sep; 53(3):716-24. PubMed ID: 6616963
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of recombinant beta-interferon given by four-hour infusion.
Grunberg SM; Kempf RA; Venturi CL; Mitchell MS
Cancer Res; 1987 Feb; 47(4):1174-8. PubMed ID: 3802098
[TBL] [Abstract][Full Text] [Related]
13. Effects of interferon on tumor tissue content in liver metastases of human carcinoid tumors.
Andersson T; Wilander E; Eriksson B; Lindgren PG; Oberg K
Cancer Res; 1990 Jun; 50(11):3413-5. PubMed ID: 2334936
[TBL] [Abstract][Full Text] [Related]
14. Treatment of metastatic carcinoid tumors and the carcinoid syndrome with recombinant interferon alpha.
Doberauer C; Mengelkoch B; Kloke O; Wandl U; Niederle N
Acta Oncol; 1991; 30(5):603-5. PubMed ID: 1892678
[TBL] [Abstract][Full Text] [Related]
15. Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma.
Kempf RA; Grunberg SM; Daniels JR; Skinner DG; Venturi CL; Spiegel R; Neri R; Greiner JM; Rudnick S; Mitchell MS
J Biol Response Mod; 1986 Feb; 5(1):27-35. PubMed ID: 3958753
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG; O'Connell MJ; Reitemeier RJ; Rubin J
Cancer Treat Rep; 1984 Apr; 68(4):665-7. PubMed ID: 6201271
[TBL] [Abstract][Full Text] [Related]
17. Treatment of metastatic carcinoid tumour with recombinant interferon alfa.
Joensuu H; Kumpulainen E; Gröhn P
Eur J Cancer; 1992; 28A(10):1650-3. PubMed ID: 1382493
[TBL] [Abstract][Full Text] [Related]
18. Interferon-induced nuclear DNA alterations in malignant carcinoid tumors in vivo.
Wilander E; Bengtsson A; Norheim I; Oberg K
J Natl Cancer Inst; 1986 Mar; 76(3):429-33. PubMed ID: 2936918
[TBL] [Abstract][Full Text] [Related]
19. Treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
Ahren B; Engman K; Lindblom A
Anticancer Res; 1992; 12(1):129-33. PubMed ID: 1567158
[TBL] [Abstract][Full Text] [Related]
20. Recombinant alpha-2b interferon in patients with malignant carcinoid tumour.
Basser RL; Lieschke GJ; Sheridan WP; Fox RM; Green MD
Aust N Z J Med; 1991 Dec; 21(6):875-8. PubMed ID: 1726359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
